Detection and treatment of subclinical tuberculosis

Tuberculosis

Volumn 92, Issue 6, 2012, Pages 447-452

  Robertson, Brian D ^a   Altmann, Danny ^b   Barry, Clif ^c   Bishai, Bill ^d   Cole, Stewart ^e   Thomas Dick, ^f   Duncan, Ken ^g   Dye, Chris ^h   Ehrt, Sabine ⁱ   Esmail, Hanif ^j   Flynn, Joanne ^k   Hafner, Richard ^c   Handley, Gray ^c   Hanekom, Willem ^l   Van Helden, Paul ^m   Kaplan, Gilla ⁿ   Kaufmann, Stefan H E ^o   Kim, Peter ^c   Lienhardt, Christian ^h   Mizrahi, Valerie ^l   Rubin, Eric ^p   Schnappinger, Dirk ⁱ   Sherman, David ^q   Thole, Jelle ^r   Vandal, Omar ^g   Walzl, Gerhard ^m   Warner, Digby ^l   Wilkinson, Robert ^l,s   Young, Douglas ^s   more..

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d AFRICA HEALTH RESEARCH INSTITUTE   (South Africa)

^e EPFL   (Switzerland)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^g BILL AND MELINDA GATES FOUNDATION   (United States)

^h WORLD HEALTH ORGANIZATION   (Switzerland)

ⁱ WEILL CORNELL MEDICAL COLLEGE   (United States)

^j IMPERIAL COLLEGE LONDON   (United Kingdom)

^k UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^l UNIVERSITY OF CAPE TOWN   (South Africa)

^m STELLENBOSCH UNIVERSITY   (South Africa)

ⁿ PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^o MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^p HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^q SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^r TuBerculosis Vaccine Initiative   (Netherlands)

^s NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

more..

Author keywords

Detection; Subclinical; Treatment; Tuberculosis

Indexed keywords

BCG VACCINE; BEDAQUILINE; PYRAZINAMIDE; TUBERCULOSTATIC AGENT;

ANTIBIOTIC THERAPY; ARTICLE; ASYMPTOMATIC INFECTION; BACTERIAL IMMUNITY; BACTERIAL LOAD; BACTERIAL TRANSMISSION; CELLULAR IMMUNITY; DISEASE MARKER; DRUG RESEARCH; HUMAN; IMMUNOMODULATION; INFECTION CONTROL; INFECTION PREVENTION; MORTALITY; NONHUMAN; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; SUBCLINICAL TUBERCULOSIS; T LYMPHOCYTE; TUBERCULOSIS; VACCINATION;

EID: 84867335224     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2012.06.004     Document Type: Note

References (41)

1. Stop-TB-Partnership The global plan to stop TB 2011-2015
2. C. Dye, and B.G. Williams The population dynamics and control of tuberculosis Science 328 2010 856 861
3. Editorial Global health in 2012: development to sustainability Lancet 379 2012
4. C. Lienhardt, M. Espinal, M. Pai, D. Maher, and M.C. Raviglione What research is needed to stop TB? Introducing the TB research movement PLoS Med 8 2011 e1001135
5. C.E. Barry 3rd, H.I. Boshoff, V. Dartois, T. Dick, S. Ehrt, J. Flynn, D. Schnappinger, R.J. Wilkinson, and D. Young The spectrum of latent tuberculosis: rethinking the biology and intervention strategies Nat Rev Microbiol 7 2009 845 855
6. WHO WHO policy on collaborative TB/HIV activities Guidelines for national programmes and other stakeholders Geneva 2012
7. T.R. Sterling, M.E. Villarino, A.S. Borisov, N. Shang, F. Gordin, E. Bliven-Sizemore, J. Hackman, C.D. Hamilton, D. Menzies, A. Kerrigan, S.E. Weis, M. Weiner, D. Wing, M.B. Conde, L. Bozeman, C.R. Horsburgh Jr., and R.E. Chaisson Three months of rifapentine and isoniazid for latent tuberculosis infection N Engl J Med 365 2011 2155 2166
8. T. Smart Thibela TB: community-wide IPT did not improve TB control in South Africa's mines at the population level 2012
9. H. Ayles, A. Schaap, A. Nota, C. Sismanidis, R. Tembwe, P. De Haas, M. Muyoyeta, and N. Beyers Prevalence of tuberculosis, HIV and respiratory symptoms in two Zambian communities: implications for tuberculosis control in the era of HIV PLoS One 4 2009 e5602
10. E.L. Corbett, T. Bandason, T. Duong, E. Dauya, B. Makamure, G.J. Churchyard, B.G. Williams, S.S. Munyati, A.E. Butterworth, P.R. Mason, S. Mungofa, and R.J. Hayes Comparison of two active case-finding strategies for community-based diagnosis of symptomatic smear-positive tuberculosis and control of infectious tuberculosis in Harare, Zimbabwe (DETECTB): a cluster-randomised trial Lancet 376 2010 1244 1253
11. N.B. Hoa, D.N. Sy, N.V. Nhung, E.W. Tiemersma, M.W. Borgdorff, and F.G. Cobelens National survey of tuberculosis prevalence in Viet Nam Bull World Health Organ 88 2010 273 280
12. T. Oni, R. Burke, R. Tsekela, N. Bangani, R. Seldon, H.P. Gideon, K. Wood, K.A. Wilkinson, T.H. Ottenhoff, and R.J. Wilkinson High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening Thorax 66 2011 669 673
13. J. Maertzdorf, D. Repsilber, S.K. Parida, K. Stanley, T. Roberts, G. Black, G. Walzl, and S.H. Kaufmann Human gene expression profiles of susceptibility and resistance in tuberculosis Genes Immun 12 2011 15 22
14. M.P. Berry, C.M. Graham, F.W. McNab, Z. Xu, S.A. Bloch, T. Oni, K.A. Wilkinson, R. Banchereau, J. Skinner, R.J. Wilkinson, C. Quinn, D. Blankenship, R. Dhawan, J.J. Cush, A. Mejias, O. Ramilo, O.M. Kon, V. Pascual, J. Banchereau, D. Chaussabel, and A. O'Garra An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis Nature 466 2010 973 977
15. R.N. Germain, M. Meier-Schellersheim, A. Nita-Lazar, and I.D. Fraser Systems biology in immunology: a computational modeling perspective Annu Rev Immunol 29 2011 527 585
16. N. Ritz, B. Dutta, S. Donath, D. Casalaz, T.G. Connell, M. Tebruegge, R. Robins-Browne, W.A. Hanekom, W.J. Britton, and N. Curtis The influence of bacille Calmette-Guerin vaccine strain on the immune response against tuberculosis: a randomized trial Am J Respir Crit Care Med 185 2012 213 222
17. M. Gengenbacher, and S.H. Kaufmann Mycobacterium tuberculosis: success through dormancy FEMS Microbiol Rev 36 2012 514 532
18. I. Keren, S. Minami, E. Rubin, and K. Lewis Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters MBio 2 2011 e00100-11
19. Flynn JL. Unpublished data.
20. N.J. Garton, S.J. Waddell, A.L. Sherratt, S.M. Lee, R.J. Smith, C. Senner, J. Hinds, K. Rajakumar, R.A. Adegbola, G.S. Besra, P.D. Butcher, and M.R. Barer Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculosis sputum PLoS Med 5 2008 e75
21. D. Schnappinger, S. Ehrt, M.I. Voskuil, Y. Liu, J.A. Mangan, I.M. Monahan, G. Dolganov, B. Efron, P.D. Butcher, C. Nathan, and G.K. Schoolnik Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment J Exp Med 198 2003 693 704
22. S.Y. Eum, J.H. Kong, M.S. Hong, Y.J. Lee, J.H. Kim, S.H. Hwang, S.N. Cho, L.E. Via, and C.E. Barry 3rd Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB Chest 137 2010 122 128
23. B.D. Robertson, and B.W. Wren Systems microbiology: current topics and applications 2012 Caister Academic Press Norfolk
24. S.P. Rao, S. Alonso, L. Rand, T. Dick, and K. Pethe The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis Proc Natl Acad Sci U S A 105 2008 11945 11950
25. K. Andries, P. Verhasselt, J. Guillemont, H.W. Gohlmann, J.M. Neefs, H. Winkler, J. Van Gestel, P. Timmerman, M. Zhu, E. Lee, P. Williams, D. de Chaffoy, E. Huitric, S. Hoffner, E. Cambau, C. Truffot-Pernot, N. Lounis, and V. Jarlier A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis Science 307 2005 223 227
26. W. Shi, X. Zhang, X. Jiang, H. Yuan, J.S. Lee, C.E. Barry 3rd, H. Wang, W. Zhang, and Y. Zhang Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis Science 333 2011 1630 1632
27. M.T. Gler, V. Skripconoka, E. Sanchez-Garavito, H. Xiao, J.L. Cabrera-Rivero, D.E. Vargas-Vasquez, M. Gao, M. Awad, S.K. Park, T.S. Shim, G.Y. Suh, M. Danilovits, H. Ogata, A. Kurve, J. Chang, K. Suzuki, T. Tupasi, W.J. Koh, B. Seaworth, L.J. Geiter, and C.D. Wells Delamanid for multidrug-resistant pulmonary tuberculosis N Engl J Med 366 2012 2151 2160
28. T. Dick, and D. Young How antibacterials really work: impact on drug discovery Future Microbiol 6 2011 603 604
29. R. Singh, U. Manjunatha, H.I. Boshoff, Y.H. Ha, P. Niyomrattanakit, R. Ledwidge, C.S. Dowd, I.Y. Lee, P. Kim, L. Zhang, S. Kang, T.H. Keller, J. Jiricek, and C.E. Barry 3rd PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release Science 322 2008 1392 1395
30. R. Tasneen, S.Y. Li, C.A. Peloquin, D. Taylor, K.N. Williams, K. Andries, K.E. Mdluli, and E.L. Nuermberger Sterilizing activity of novel TMC207- and PA-824-containing regimens in a murine model of tuberculosis Antimicrob Agents Chemother 55 2011 5485 5492
31. P.L. Lin, M. Rodgers, L. Smith, M. Bigbee, A. Myers, C. Bigbee, I. Chiosea, S.V. Capuano, C. Fuhrman, E. Klein, and J.L. Flynn Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model Infect Immun 77 2009 4631 4642
32. J.E. Golub, R.E. Chaisson, and N.A. Martinson Additive effects of isoniazid preventive therapy and HAART AIDS 23 2009 1446 1447
33. G. Meintjes, H. Rabie, R.J. Wilkinson, and M.F. Cotton Tuberculosis-associated immune reconstitution inflammatory syndrome and unmasking of tuberculosis by antiretroviral therapy Clin Chest Med 30 2009 797 810 [x]
34. K.A. Wilkinson, R. Seldon, G. Meintjes, M.X. Rangaka, W.A. Hanekom, G. Maartens, and R.J. Wilkinson Dissection of regenerating T-cell responses against tuberculosis in HIV-infected adults sensitized by Mycobacterium tuberculosis Am J Respir Crit Care Med 180 2009 674 683
35. C. Kuijl, N.D. Savage, M. Marsman, A.W. Tuin, L. Janssen, D.A. Egan, M. Ketema, R. van den Nieuwendijk, S.J. van den Eeden, A. Geluk, A. Poot, G. van der Marel, R.L. Beijersbergen, H. Overkleeft, T.H. Ottenhoff, and J. Neefjes Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1 Nature 450 2007 725 730
36. D.M. Tobin, F.J. Roca, S.F. Oh, R. McFarland, T.W. Vickery, J.P. Ray, D.C. Ko, Y. Zou, N.D. Bang, T.T. Chau, J.C. Vary, T.R. Hawn, S.J. Dunstan, J.J. Farrar, G.E. Thwaites, M.C. King, C.N. Serhan, and L. Ramakrishnan Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections Cell 148 2012 434 446
37. S. Subbian, L. Tsenova, P. O'Brien, G. Yang, M.S. Koo, B. Peixoto, D. Fallows, V. Dartois, G. Muller, and G. Kaplan Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungs PLoS Pathog 7 2011 e1002262
38. S.H. Kaufmann Future vaccination strategies against tuberculosis: thinking outside the box Immunity 33 2010 567 577
39. K. Kupferschmidt Infectious disease. Taking a new shot at a TB vaccine Science 334 2011 1488 1490
40. C. Aagaard, T. Hoang, J. Dietrich, P.J. Cardona, A. Izzo, G. Dolganov, G.K. Schoolnik, J.P. Cassidy, R. Billeskov, and P. Andersen A multistage tuberculosis vaccine that confers efficient protection before and after exposure Nat Med 17 2011 189 194
41. D. Young, J. Stark, and D. Kirschner Systems biology of persistent infection: tuberculosis as a case study Nat Rev Microbiol 6 2008 520 528